The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review
Open accessAbstract
Untreated attention-deficit/hyperactivity disorder (ADHD) can lead to substantial adverse social, economic, and emotional outcomes for patients. The effectiveness of current pharmacologic treatments is often reduced, due to low treatment adherence and medication discontinuation. This current systematic literature review analyzes the current state of knowledge surrounding ADHD medication discontinuation, focusing on: 1) the extent of patient persistence; 2) adherence; and 3) the underlying reasons for patients' treatment discontinuation and how discontinuation rates and reasons vary across patient subgroups. We selected 91 original studies (67 with persistence/discontinuation results, 26 with adherence results, and 41 with reasons for discontinuation, switching, or nonadherence) and 36 expert opinion reviews on ADHD medication discontinuation, published from 1990 to 2013. Treatment persistence on stimulants, measured by treatment duration during the 12-month follow-up periods, averaged 136 days for children and adolescents and 230 days for adults. Owing to substantial study heterogeneity, comparisons across age or medication type subgroups were generally inconclusive; however, long-acting formulations and amphetamines were associated with longer treatment duration than short-acting formulations and methylphenidates. The medication possession ratio, used to measure adherence, was <0.7 for all age groups and medication classes during a 12-month period. Adverse effects were the most commonly cited reason for discontinuation in all studies. Original research studies reported the lack of symptom control as a common discontinuation reason, followed by dosing inconvenience, social stigma associated with ADHD medication, and the patient's attitude. In summary, although there was a lack of consistency in the measurement of adherence and persistence, these findings indicate that drug adherence and persistence are generally poor among patients with ADHD. Clinicians may be able to help improve adherence and persistence to ADHD treatment by educating caregivers and patients on treatment goals, administering long-acting medications, and following-up with patients to verify if medication is still effective and well-tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Greenhalgh, T., & Peacock, R. (2005) · BMJ · doi:10.1136/bmj.38636.593461.68 · Cited by 2,045
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Shaw, M., Hodgkins, P., Caci, H., Young, S., Kahle, J., Woods, A. G., & Arnold, L. E. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-99 · Cited by 759
Compliance With Medication Regimens for Mental and Physical Disorders
Cramer, J. A., & Rosenheck, R. (1998) · Psychiatric Services · doi:10.1176/ps.49.2.196 · Cited by 725
Clinical and Functional Outcome of Childhood Attention-Deficit/Hyperactivity Disorder 33 Years Later
Klein, R. G., Mannuzza, S., Olazagasti, M. A. R., Roizen, E., Hutchison, J. A., Lashua, E. C., & Castellanos, F. X. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.271 · Cited by 619
Wolraich, M. L., Wibbelsman, C. J., Brown, T. E., Evans, S. W., Gotlieb, E. M., Knight, J. R., Ross, E. C., Shubiner, H. H., Wender, E. H., & Wilens, T. (2005) · Pediatrics · doi:10.1542/peds.2004-1959 · Cited by 404
European guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374
Review of Medication Adherence in Children and Adults with ADHD
Adler, L. D., & Nierenberg, A. A. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.01.2112 · Cited by 295
Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults
McCarthy, S., Asherson, P., Coghill, D., Hollis, C., Murray, M., Potts, L., Sayal, K., de Soysa, R., Taylor, E., Williams, T., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.045245 · Cited by 215
Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD
THIRUCHELVAM, D., CHARACH, A., & SCHACHAR, R. J. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200108000-00014 · Cited by 172
Continuity of Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder
Marcus, S. C., Wan, G. J., Kemner, J. E., & Olfson, M. (2005) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.159.6.572 · Cited by 163
Swanson, J. (2003) · CNS Drugs · doi:10.2165/00023210-200317020-00004 · Cited by 162
Gau, S. S. F., Shen, H.-Y., Chou, M.-C., Tang, C.-S., Chiu, Y.-N., & Gau, C.-S. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.286 · Cited by 148 · cited 1×
“Compared with database studies on adherence, patient and parent/caregiver surveys were conducted over a wider geographic area: two in the US; 56,57 three in Taiwan; 49,58,59 and the remaining five in Norway, 43 India, 60 Spain, 55 Canada, 61 a nd Saudi Arabia.”
Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0286-5 · Cited by 147
Medication nonadherence and psychiatry
Chapman, S. C. E., & Horne, R. (2013) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283642da4 · Cited by 142
Perwien, A. R., Hall, J., Swensen, A., & Swindle, R. (2004) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2004.10.2.122 · Cited by 136
Assessment of Adherence Measures with Different Stimulants Among Children and Adolescents
Sanchez, R. J., Crismon, M. L., Barner, J. C., Bettinger, T., & Wilson, J. P. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.7.909 · Cited by 101 · cited 1×
“76 for patients receiving LA MPH for 6 months.(24,42) For studies using an MPR cut-off of 0.”
BackgroundHodgkins, P., Setyawan, J., Mitra, D., Davis, K., Quintero, J., Fridman, M., Shaw, M., & Harpin, V. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-1969-8 · Cited by 92 · cited 1×
“4% (for 6–17 year old western European patients with ADHD evaluated for a minimum of 2 years postdiagnosis).(64) As with prior adherence assessments, this analysis was limited by the heterogeneity of methodologies across studies and by small sample sizes.”
BackgroundBarkley, R. A. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1907 · Cited by 71
Wu, E. Q., Hodgkins, P., Ben-Hamadi, R., Setyawan, J., Xie, J., Sikirica, V., Du, E. X., Yan, S. Y., & Erder, M. H. (2012) · CNS Drugs · doi:10.2165/11633900-000000000-00000 · Cited by 58
Self-citationCardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD
Winterstein, A. G., Gerhard, T., Shuster, J., & Saidi, A. (2009) · Pediatrics · doi:10.1542/peds.2008-3138 · Cited by 56
Ramos-Quiroga, J. A., Bosch, R., Castells, X., Valero, S., Nogueira, M., Gómez, N., Yelmo, S., Ferrer, M., Martínez, Y., & Casas, M. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00005 · Cited by 54 · cited 1×
“Of the ten survey studies, three compared adherence between LA and SA stimulants.(43,49,55) Among these three studies, LA stimulants were found to have better adherence (ranging between 74.”
BackgroundEffects of stimulant medication on cognitive performance of children with ADHD.
Gimpel, G. A., Collett, B. R., Veeder, M. A., Gifford, J. A., Sneddon, P., Bushman, B., Hughes, K., & Odell, J. D. (2005) · Clinical Pediatrics · doi:10.1177/000992280504400504 · Cited by 39 · cited 1×
“Compared with database studies on adherence, patient and parent/caregiver surveys were conducted over a wider geographic area: two in the US; 56,57 three in Taiwan; 49,58,59 and the remaining five in Norway, 43 India, 60 Spain, 55 Canada, 61 a nd Saudi Arabia.”
ResultChou, W., Chou, M., Tzang, R., Hsu, Y., Gau, S. S., Chen, S., Wu, Y., Huang, Y., Liang, H., & Cheng, H. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01937.x · Cited by 36
Approaching ADHD as a Chronic Condition: Implications for Long-Term Adherence
Van Cleave, J., & Leslie, L. K. (2008) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20080801-07 · Cited by 35
The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder
Ashton, H., Gallagher, P., & Moore, B. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106061710 · Cited by 31
Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder
Weisler, R. H. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.6.745 · Cited by 22
Cited by
Young, S., Adamo, N., Ásgeirsdóttir, B. B., Branney, P., Beckett, M., Colley, W., Cubbin, S., Deeley, Q., Farrag, E., Gudjonsson, G., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02707-9 · Cited by 610
Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD
Davis, N. O., Bower, J., & Kollins, S. H. (2018) · PLOS ONE · doi:10.1371/journal.pone.0189749 · Cited by 106
Soff, C., Sotnikova, A., Christiansen, H., Becker, K., & Siniatchkin, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1646-y · Cited by 111
Sotnikova, A., Soff, C., Tagliazucchi, E., Becker, K., & Siniatchkin, M. (2017) · Brain Topography · doi:10.1007/s10548-017-0552-4 · Cited by 85
Janssen, L., Kan, C. C., Carpentier, P. J., Sizoo, B., Hepark, S., Schellekens, M. P. J., Donders, A. R. T., Buitelaar, J. K., & Speckens, A. E. M. (2019) · Psychological Medicine · doi:10.1017/s0033291718000429 · Cited by 78
Metadata
- Authors
- Sikirica, V., Lu, M., Greven, P., Zhong, Y., Qin, P., Xie, J., & Gajria, K.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2014-08
- Volume
- 10
- Pages
- 1543
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- OpenAlex
- W1997101492
- Cited by
- 206
- References
- 30
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.